• Profile
Close

Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition

Virchows Archiv Jan 29, 2020

Maffeis V, Cappellesso R, Galuppini F, et al. - Researchers intended to evaluate tumor budding (TB) in intestinal-type adenocarcinoma (ITAC) and to assess its possible correlation with EMT markers in this setting. They included 32 surgically resected specimens of non-mucinous/non-signet ring ITAC and assessed them for TB according to the international recommendations developed for CRC. They examined the expression of the EMT markers E-cadherin, ZEB1, ZEB2, SLUG, and SNAIL by immunohistochemistry (IHC). They found TB in 13/32 (40.6%) ITAC cases including the 7 individuals with relapse and the 4 individuals dead of disease. A correlation was found between lymphovascular invasion and TB. The absence of TB was correlated with low ZEB2 expression. The data indicated that TB is correlated with a worse prognosis in ITAC, but the findings do not appear to support the involvement of EMT in this specific setting. future larger studies are required to discuss this point.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay